His revised target price is line with the 12% increase in SMG’s price since the announcement. Teng believes it will give the counter a 39.4% upside from its 33 cent price on Jan 11.
UOB Kay Hian (UOBKH) is maintaining its “buy” call on private specialist and healthcare services provider Singapore Medical Group (SMG), but at a higher target price of 46 cents.
This is up 9 cents from its previous 37 cent call and follows the group’s Dec 18 2020, disclosure of a possible transaction involving the company’s shares, analyst Lucas Teng explains in a Jan 11.
